Das Klinikum
Dr. Yogesh Singh
Research Scientist/Group Leader
Medical Genetics and Applied Genomics
NGS Competence Centre Tübingen (NCCT)
Research Institute of Women's Hospital
Calwerstraße 7, 72076
Tübingen, Germany
Kontakt
Telefonnummer: 07071 29-78264
E-Mail-Adresse: yogesh.singh@med.uni-tuebingen.de
Klinik / Institut / Zentrum
Klinische Schwerpunkte
- Cellular and Genomic Immunology
- Microbiome and Inflammation
Wissenschaftliche Tätigkeit
- COVID19: Understanding the function of antigen-specific (TCR/BCR) in COVID-19 using multi-OMICS tools
- Track.a.TCR: COVID-19 vaccination and Long-term immune response
- Neurodegeneration: Innate and adaptive immune response after the gut microbiome manipulation in Parkinson's disease (PD)
Publikationen
- Singh Y, Trautwein C, Fendel R, Krickeberg N, Held J, Kreidenweiss A, Berezhnoy B, Bissinger R, Ossowski S, Salker MS, Casadei N, Riess O, the Deutsche COVID-19 OMICS Initiative (DeCOI). SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of immune cells. 2021. Heliyon. https://doi.org/10.1016/j.heliyon.2021.e07147
- Singh Y, Trautwein C, Dhariwal A, Salker M, Alauddin M, Zizmare L, Pelzl L, Feger M, Admard J, Casadei N, Föller M, Pachauri V, Park D, Mak T, Frick J, Lang F, Riess O. DJ-1 (Park7) affects the gut microbiome, metabolites, and development of innate lymphoid cells. 2020. Scientific Reports
- Zhang S, al-Maghout T, Cao H, Pelzl L, Salker M, Veldhoen M, Cheng A, Lang F, Singh Y. Gut bacterial metabolit Urolithin A (UA) mitigates Ca2+ entry in T cells by regulating miRNA-10a-5p. Front. Immunology, 2019.
- Zur vollständigen Publikationsliste